| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |